The Scientist

» NIH and immunology

Most Recent

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

image: Image of the Day: Works In Progress

Image of the Day: Works In Progress

By | April 5, 2017

An NIH survey of 351 individuals in the research community has shown that many are supportive of interim research products like preprints.

0 Comments

Both Democrats and Republications criticize the Trump administration’s plan to cut funding for biomedical research.

0 Comments

image: The Invention Return on NIH Investments

The Invention Return on NIH Investments

By | April 2, 2017

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

image: Infographic: Antibody Cancer Therapy

Infographic: Antibody Cancer Therapy

By | April 1, 2017

An experimental technique removes T cells that aid in vitro tumor growth.

3 Comments

image: Infographic: Targeting Cancer Antigens

Infographic: Targeting Cancer Antigens

By | April 1, 2017

Neoantigens may serve as valuable targets for new immunotherapies.

0 Comments

image: Targeting Tregs Halts Cancer’s Immune Helpers

Targeting Tregs Halts Cancer’s Immune Helpers

By | April 1, 2017

New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech